The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: Gender-related differences

Renal Failure

Volumn 34, Issue 8, 2012, Pages 1046-1051

  Haghighi, Maryam ^a   Nematbakhsh, Mehdi ^a,c   Talebi, Ardeshir ^a   Nasri, Hamid ^a,c   Ashrafi, Farzaneh ^a   Roshanaei, Kambiz ^b   Eshraghi Jazi, Fatemeh ^a   Pezeshki, Zahra ^a   Safari, Tahereh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Biology   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin II; AT1; Cisplatin; Gender; Nephrotoxicity; Rat

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CISPLATIN; CREATININE; LOSARTAN; MAGNESIUM; NITRITE; PROTEIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; KIDNEY MASS; MAGNESIUM BLOOD LEVEL; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD UREA NITROGEN; CISPLATIN; CREATININE; FEMALE; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LOSARTAN; MALE; RATS; RATS, WISTAR; SEX FACTORS;

EID: 84865264873     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.700886     Document Type: Article

References (35)

1. Silbiger SR, Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther. 2003;10(1):3-14.
2. McGuinness SJ, Ryan MP. Mechanism of cisplatin nephrotoxicity in rat renal proximal tubule suspensions. Toxicol In Vitro. 1994;8(6):1203-1212.
3. Miller RP, Tadagavadi RK, Ramesh G, ReevesWB.Mechanisms of cisplatin nephrotoxicity. Toxins. 2010;2:2490-2518.
4. Santos NA, Catao CS, Martins NM, Curti C, Bianchi ML, Santos AC. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch Toxicol. 2007;81(7):495-504.
5. Wei Q, Wang MH, Dong Z. Differential gender differences in ischemic and nephrotoxic acute renal failure. Am J Nephrol. 2005;25(5):491-499.
6. Ajith TA, Abhishek G, Roshny D, Sudheesh NP. Cosupplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice. Exp Toxicol Pathol. 2009;61(6):565-571.
7. Appenroth D, Frob S, Kersten L, Splinter FK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997;71(11):677-683.
8. Saleh S, El-Demerdash E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: Role of nitric oxide. Basic Clin Pharmacol Toxicol. 2005;97(2):91-97.
9. Sayed-Ahmed MM, Eissa MA, Kenawy SA, Mostafa N, Calvani M, Osman AM. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model. Chemotherapy. 2004;50(4):162-170.
10. Uzunoglu S, Karagol H, Ozpuyan F, et al. Protective effect of L-carnitine versus amifostine against cisplatininduced nephrotoxicity in rats. Med Oncol. 2011;28(Suppl. 1): S690-S696.
11. Goncalves AR, Fujihara CK, Mattar AL, et al. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: Strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory. Am J Physiol Renal Physiol. 2004;286(5): F945-F954.
12. Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther. 2007;323(1):85-93.
13. Deegan PM, Nolan C, Ryan MP, Basinger MA, Jones MM, Hande KR. The role of the renin-angiotensin system in cisplatin nephrotoxicity. Ren Fail. 1995;17(6):665-674.
14. Saleh S, Ain-Shoka AA, El-Demerdash E, Khalef MM. Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury. Chemotherapy. 2009;55(6): 399-406.
15. Stakisaitis D, Dudeniene G, Jankunas RJ, Grazeliene G, Didziapetriene J, Pundziene B. Cisplatin increases urinary sodium excretion in rats: Gender-related differences. Medicina (Kaunas). 2010;46(1):45-50.
16. Sampson AK, Moritz KM, Jones ES, Flower RL, Widdop RE, Denton KM. Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension. 2008;52(4):666-671.
17. Hilliard LM, Nematbakhsh M, Kett MM, et al. Gender differences in pressure-natriuresis and renal autoregulation: Role of the angiotensin type 2 receptor. Hypertension. 2011;57(2):275-282.
18. Kaschina E, Angiotensin UT. AT1/AT2 receptors: Regulation, signalling and function. Blood Press. 2003;12(2):70-88.
19. Carey RM. Update on the role of the AT2 receptor. Curr Opin Nephrol Hypertens. 2005;14(1):67-71.
20. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52(3):415-472.
21. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991;88(3):921-933.
22. Perlegas D, Xie H, Sinha S, et al. The angiotensin type-2 receptor regulates smooth muscle growth and force generation in late fetal mouse development. Am J Physiol Heart Circ Physiol. 2004;288(1):H96-H102.
23. Silva-Antonialli MM, Tostes RC, Fernandes L, et al. A lower ratio of AT1/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats. Cardiovasc Res. 2004;62(3):587-593.
24. Armando I, Jezova M, Juorio AV, et al. Estrogen upregulates renal angiotensin II AT(2) receptors. Am J Physiol Renal Physiol. 2002;283(5):F934- F943.
25. Nickenig G, Baumer AT, Grohe C, et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 1998;97(22):2197-2201.
26. Santos RA, Campagnole-Santos MJ, Andrade SP. Angiotensin- (1-7): An update. Regul Pept. 2000;91(1-3):45-62.
27. Sullivan JC, Bhatia K, Yamamoto T, Elmarakby AA. Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats. Hypertension. 2010;56(4):658-666.
28. Miller JA, Cherney DZ, Duncan JA, et al. Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol. 2006;17(9):2554-2560.
29. Souza dos Santos RA, Passaglio KT, Pesquero JB, Bader M, Simões E Silva AC. Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels. Hypertension. 2001;38(3):660-664.
30. Carson P, Giles T, Higginbotham M, Hollenberg N, Kannel W, Siragy HM. Angiotensin receptor blockers: Evidence for preserving target organs. Clin Cardiol. 2001;24(3):183-190.
31. Ruster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006;17(11): 2985-2991.
32. Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications. Kidney Int. 2005;67(3):799-812.
33. Vazquez E, Coronel I, Bautista R, et al. Angiotensin IIdependent induction of AT(2) receptor expression after renal ablation. Am J Physiol Renal Physiol. 2005;288(1): F207-F213.
34. Unger T. The angiotensin type 2 receptor: Variations on an enigmatic theme. J Hypertens. 1999;17(12 Pt. 2):1775-1786.
35. Tauler P, Ferrer MD, Romaguera D, et al. Antioxidant response and oxidative damage induced by a swimming session: Influence of gender. J Sports Sci. 2008;26(12): 1303-1311.